TC BIOPHARM (HOLDINGS) PLC (TCBP) Financial Statements
TC BIOPHARM (HOLDINGS) PLC (TCBP) files with the U.S. Securities and Exchange Commission under CIK 0001872812. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2024
- Net Income
- -12.15 million GBP
- Total Assets
- 8.33 million GBP
- Net Cash from Operations
- -12.57 million GBP
Fiscal year ended Dec 31, 2024. Latest periodic SEC filing: May 9, 2025. Source: SEC filings (EDGAR XBRL). Amounts in GBP.
Open the full financial statements for TCBP in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History